CN108531439A - A kind of Recombinant organism and its construction method and application - Google Patents
A kind of Recombinant organism and its construction method and application Download PDFInfo
- Publication number
- CN108531439A CN108531439A CN201810336575.9A CN201810336575A CN108531439A CN 108531439 A CN108531439 A CN 108531439A CN 201810336575 A CN201810336575 A CN 201810336575A CN 108531439 A CN108531439 A CN 108531439A
- Authority
- CN
- China
- Prior art keywords
- fimh
- recombinant
- fermentation
- escherichia coli
- recombinant organism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010276 construction Methods 0.000 title claims abstract description 10
- 101150015947 fimH gene Proteins 0.000 claims abstract description 33
- 239000013612 plasmid Substances 0.000 claims abstract description 33
- 241000588724 Escherichia coli Species 0.000 claims abstract description 29
- 241000894006 Bacteria Species 0.000 claims abstract description 28
- 238000000855 fermentation Methods 0.000 claims abstract description 28
- 230000004151 fermentation Effects 0.000 claims abstract description 28
- 238000010353 genetic engineering Methods 0.000 claims abstract description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 42
- 239000004473 Threonine Substances 0.000 claims description 24
- 229960002898 threonine Drugs 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 230000006798 recombination Effects 0.000 claims description 3
- 238000005215 recombination Methods 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- 210000002429 large intestine Anatomy 0.000 claims 1
- 235000008521 threonine Nutrition 0.000 abstract description 10
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 150000003588 threonines Chemical class 0.000 abstract description 4
- 244000005706 microflora Species 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 26
- 239000007788 liquid Substances 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 229920000297 Rayon Polymers 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229960001031 glucose Drugs 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000305071 Enterobacterales Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- KVCWSJZUKMSPLM-UHFFFAOYSA-N O.O[PH2]=O Chemical compound O.O[PH2]=O KVCWSJZUKMSPLM-UHFFFAOYSA-N 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- VIEUIBSXXCVYNO-UHFFFAOYSA-N acetonitrile isothiocyanatobenzene Chemical compound C(C)#N.C1(=CC=CC=C1)N=C=S VIEUIBSXXCVYNO-UHFFFAOYSA-N 0.000 description 1
- PVDVPOZEJCXUAM-UHFFFAOYSA-N acetonitrile;n,n-diethylethanamine Chemical compound CC#N.CCN(CC)CC PVDVPOZEJCXUAM-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940117953 phenylisothiocyanate Drugs 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a kind of Recombinant organism, the recombinant plasmid for carrying fimH genes has been imported.The invention also discloses the construction methods of genetic engineering bacterium.The present invention further discloses application of the genetic engineering bacterium in fermenting and producing L threonines.The present invention is overexpressed the Recombinant organism of fimH genes by structure, make Escherichia coli biomembrane output increased during L threonines are produced in fermentation, and adhesion increases, Microflora increases, the yield of L threonines and sugared conversion ratio are improved, fermentation period is shortened.
Description
Technical field
The present invention relates to L-threonine fermentations, and in particular to a kind of Recombinant organism and its construction method with answer
With.
Background technology
L-threonine be detached and identified from fibrin hydrolysate by W.C.Rose nineteen thirty-fives Lai a kind of ammonia
Base acid, has been demonstrated that it is the essential amino acid being finally found, human body itself cannot synthesize, it is necessary to be absorbed from food.L- revives
Propylhomoserin is widely used in feed industry, health food and medical industry as food additives, since the effect of L-threonine is wide
General, the market demand rapid growth of global threonine, the market of the following threonine will quickly increase in recent years, the need of threonine
The amount of asking also will constantly increase.
The preparation method of L-threonine mainly has protein Hydrolyze method, chemical synthesis, microbe fermentation method, microorganism hair
The advantages that ferment method, which has, to economize on resources, at low cost, and environmental pollution is small, has been widely used in L-threonine production.With existing
Generation social technique for gene engineering it is like flying push ahead vigorously, industrial microorganism and industrial technology application demand amount increase, especially industrial micro-
The structure of bio-carrier system produces the screening of bacterial strain for excellent L-threonine and the raising of acid yield provides reliable skill
Art guarantee makes microorganism direct fermentation production L-threonine become a kind of cheap industrialized preparing process.At this stage can
The microorganism of production threonine has Escherichia, corynebacterium, Serratia etc..It is now general that Escherichia coli produce threonine
All over applying in Fermentation Experiment, its advantage is that culture propagation is fast, fermentation period is short, it is at low cost the features such as, but relative to
The demand of amino acid industry, although stable yield increases, speed or slow.
Invention content
Goal of the invention:In order to solve low output when existing Escherichia coli fermentation produces L-threonine, fermentation period length is asked
Topic, the present invention provides a kind of Recombinant organisms, and invention further provides the bacillus coli gene engineerings
The construction method of bacterium, the present invention further provide the Recombinant organism in production of L-threonine by fermentation
Application.
Technical solution:A kind of Recombinant organism of the present invention has imported the recombination for carrying fimH genes
Plasmid.For the present invention from medical domain, the formation of most of bacterium infection and biomembrane is closely bound up, uses and subtracts in medicine
The formation of few biomembrane reduces the infection of bacterium;Present invention firstly provides the biofilm biomasses by increasing Escherichia coli to increase
The adhesiveness of Escherichia coli can be adhered to inanimate surfaces, improve L-threonine during production of L-threonine by fermentation
Yield and fermentation period.
Wherein, the original Escherichia coli are CCTCC NO:M 2015233;The recombinant plasmid is to carry fimH genes
PET-28a plasmids.
The present invention further provides the construction method of the Recombinant organism, includes the following steps:
(1) genome of original Escherichia coli is extracted;
(2) genome obtained using step (1) extraction expands fimH genes as template using round pcr;
(3) the fimH genes for obtaining step (2) are inserted between I/Xba of Nco, I restriction enzyme sites of PET-28a plasmids, are taken
Recombinant plasmid with fimH genes;
(4) in the recombinant plasmid transformed for obtaining step (3) to the competent cell of E.coli DH5 α, from E.coliDH5
Recombinant plasmid is extracted in α;
(5) to get big in the recombinant plasmid transformed to the competent cell of original Escherichia coli for obtaining step (4) extraction
Enterobacteria genetic engineering bacterium.
Wherein, original Escherichia coli described in step (1) are given from Shanghai Inst. of Life Science, CAS, described big
Enterobacteria patent applied for 201510199036.1 has simultaneously carried out preservation, and deposit number is CCTCC NO:M 2015233, bacterial strain
Number be CIBTS1688.
Wherein, the primer that PCR is used described in step (2) is as follows:
fimH-F:GGATAACAATTCCCCTCTAGAATGAAACGAGTTATTACCCTGTTTGC
fimH-R:GATGATGGCTGCTGCCCATGGTTATTGATAAACAAAAGTCACGCCA.
The present invention further provides application of the Recombinant organism in production of L-threonine by fermentation.
Wherein, fermentation condition is as follows:Fermentation temperature is 25~37 DEG C, and fermentation time is 30~32h.
Advantageous effect:The present invention is overexpressed the Recombinant organism of fimH genes by structure, makes Escherichia coli
Biomembrane output increased during L-threonine is produced in fermentation, adhesion increase, and Microflora increases, and improves L-threonine
Yield and sugared conversion ratio, shorten fermentation period.
Description of the drawings
Fig. 1 is the electrophoretogram of original genome of E.coli;
Fig. 2 is the electrophoretogram of fimH genes;
Fig. 3 is the electrophoretogram of recombinant plasmid;
Fig. 4 is the collection of illustrative plates of recombinant plasmid;
Fig. 5 is the biomembrane electron microscope of bacterial strain CIBTS1688;
Fig. 6 is the biomembrane electron microscope of bacterial strain CIBTS1688fimH*;
Fig. 7 is the fermentation results of bacterial strain CIBTS1688 and bacterial strain CIBTS1688fimH*.
Specific implementation mode
Embodiment 1
One, original Escherichia coli CIBTS1688 genomes are extracted
Kit (the takara minibest bacteria genomic of bacterial genomes are extracted using takara companies
DNA extractionkit ver.3.0)
(1) glycerol stock activates:10 μ L original strain CIBTS1688+5mL LB liquid mediums, are incubated overnight;
Wherein, LB liquid medium formula is as follows:Sodium chloride 10g/L, tryptone 10g/L, yeast powder 5g/L, 121 DEG C,
Sterilize 20min;
(2) 1.5mL centrifuge tubes is used to collect bacterium solution (per 1.5mL centrifuge tube dress 1.2mL bacterium solutions), 12000rpm centrifuges 2min,
Abandon supernatant;
(3) buffer GL of 180 μ L, the Proteinase K (20mg/ of 20 μ L are added in the thalline obtained to step (2)
ML) and the RNase A of 10 μ L (10mg/mL) fully vibrate mixing, and in 56 DEG C of water-bath warm bath 10min, solution is transparent, clear at this time
Clear shape;
(4) absolute ethyl alcohol of the buffer GB and 200 μ L of 200 μ L are added in the system obtained to step (3), fully inhales
Beat mixing;
(5) Spin Column are mounted on Collection Tube, the solution that step (4) obtains moves to Spin
In Column, 12000rpm centrifuges 2min, abandons filtrate;
(6) the Buffer WA of 500 μ L are added into Spin Column, 12000rpm centrifuges 1min, abandons filtrate;
(7) the Buffer WB of 700 μ L are added into Spin Column, 12000rpm centrifuges 1min, abandons filtrate;
(8) Buffer WB are added along Spin Column tube wall surroundings, help to rinse the salt attached on tube wall completely;
(9) repetitive operation step (8);
(10) Spin Column are placed on Collection Tube, 12000rpm centrifuges 2min;
(11) Spin Column are placed on new 1.5mL centrifuge tubes, are added in the centre of Spin Column films
The aqua sterilisa or Elution Buffer of 50~200 μ L, is stored at room temperature 5min;Wherein, aqua sterilisa is heated to 65 DEG C of uses has
Conducive to raising elution efficiency;
(12) and then 12000rpm centrifuges 2min eluted dnas.If you need to obtain bigger receipts amount, can will be rejoined from lower liquid
The center of Spin Column films or the aqua sterilisa for adding 50~200 μ L, after being stored at room temperature 5min, 12000rpm centrifuges 2min
The electrophoretogram of eluted dna, original e. coli dna is shown in Fig. 1.
Two, with round pcr amplifying target genes fimH
(1) DNA obtained using step 1 is template, and with round pcr amplifying target genes fimH, reaction system is shown in Table 1;
fimH-F:GGATAACAATTCCCCTCTAGAATGAAACGAGTTATTACCCTGTTTGC
fimH-R:GATGATGGCTGCTGCCCATGGTTATTGATAAACAAAAGTCACGCCA
1 PCR reaction systems of table
Electrophoresis, knot are carried out to above-mentioned PCR product (fimH genetic fragments) using 0.8% (0.8g/100mL) Ago-Gel
Fruit sees Fig. 2.
(2) glue recovery purifying segment fimH
Use takara kits (TaKaRa MiniBEST Agarose Gel DNA Extraction Kit
Ver.4.0)
2.1 make Ago-Gels using tbe buffer liquids, then to target fragment fimH into row agarose gel electrophoresis;
2.2 cut out the Ago-Gel containing target fragment fimH in the UV lamp, and surface liquid is exhausted with paper handkerchief;
2.3 chopping blob of viscoses, weigh blob of viscose weight.When calculating volume, calculated with 1mg=1 μ L;
2.4 are added lysate Buffer GM, Buffer GM dosages into blob of viscose did not had blob of viscose, after evenly mixing room
15~25 DEG C of dissolving blob of viscoses of temperature, should be interrupted oscillation mixing, blob of viscose is made fully to dissolve at this time;
2.5 are placed in the Spin Colum in kit on Collection Tube;
2.6 are transferred to the solution that step 2.4 obtains in Spin Column, and 12 00000rpm centrifuge 1min, abandon filtrate;
2.7 the Buffer WB of 700 μ L are added in Spin Column, and room temperature 12000rpm centrifuges 1min, abandons filtrate;
2.8 repetitive operation steps 2.7;
2.9 are placed in Spin Column on Collection Tube, and room temperature 12000rpm centrifuges 1min, abandons filtrate;
2.10 are placed in Spin Column on the centrifuge tube of new 1.5mL, add in the centre of Spin Column films
Enter 30 μ L aqua sterilisas, is stored at room temperature 1min;
2.11 room temperature 12000rpm centrifugations 1min elute fimH segments;
2.12 pairs of fimH target fragments after purification are verified into row agarose gel electrophoresis, calculate concentration;Wherein fimH bases
The nucleotide sequence of cause is shown in SEQ ID NO:1.
Three, extraction plasmid PET-28a
It utilizes takara kits (TaKaRa MiniBEST Plasmid Purification Kit Ver.4.0)
(1) E.coli DH5 α single bacterium colonies are selected from plating medium (to include PET-28a, from Ke Lei biotechnologies have
Limit company, nucleotide sequence are shown in SEQ ID NO:2), wherein E.coli DH5 α give birth to work bioengineering (Shanghai) stock purchased from Shanghai
Part Co., Ltd, the store method of NO.B528413, PET-28a refer to according to《Molecular Cloning:A Laboratory guide》(Huang Peitang etc. is translated,
China, Science Press, 2002, the third edition) in method carry out;Then the LB Liquid Cultures containing antibiotic of 5mL are seeded to
In base (resistance is 50 μ g/mL of kanamycins), 37 DEG C are incubated overnight 12~16h;
(2) bacterium solution that is incubated overnight of 1~4mL, 12000rpm is taken to centrifuge 2min, abandon supernatant;
(3) with the Solution I (A containing RNase) of 250 μ L fully suspended bacterial precipitations;
(4) Solution II that 250 μ L are added gently spins upside down mixing 5~6 times, and thalline is made fully to crack, and is formed saturating
Bright solution;
(5) Solution III of 4 DEG C of precoolings of 350 μ L is added, gently spins upside down mixing 5~6 times, until forming consolidation
It is aggregated block, is then stored at room temperature 2min;
(6) room temperature 12000rpm centrifuges 10min, takes supernatant;
(7) the Spin Column in kit are placed on Collection Tube;
(8) supernatant that step (6) obtains is transferred in Spin Column, 12000rpm centrifuges 1min, abandons filtrate;
(9) the Buffer WA of 500 μ L are added in Spin Column, 12000rpm centrifuges 1min, abandons filtrate;
(10) the Buffer WB of 700 μ L are added in Spin Column, 12000rpm centrifuges 1min, abandons filtrate;
(11) repetitive operation step (10);
(12) Spin Column are placed on Collection Tube again, 12000rpm centrifuges 1min, eliminates residual
Stay washing lotion;
(13) Spin Column are placed on the centrifuge tube of new 1.5mL, are added in the centre of Spin Column films
65 DEG C of aqua sterilisas for entering 30~50 μ L, are stored at room temperature 1min;
(14) 12000rpm centrifuges 1min eluted dnas;
(15) the plasmid PET-28a after extraction is verified into row agarose gel electrophoresis, calculates concentration.
Four, I double digestion plasmid PET28a of restriction enzyme Nco I and Xba is utilized
2 enzymatic hydrolysis system of table
Five, plasmid PET28a obtains recombinant plasmid PET28a+fimH after connecting target gene fimH and double digestion
One-step cloning kit is only praised using promiseIt is formulated as follows reaction system in ice-water bath, sees
Table 3.
3 enzyme disjunctor system of table
Six, recombinant plasmid PET28a+fimH is transformed into E.coli DH5 α
(1) 200 μ L E.coli DH5 α competent cells of a pipe are taken out from -80 DEG C of refrigerators (gives birth to work bioengineering in Shanghai
(Shanghai) limited liability company NO.B528413)) suspension, thaws, is immediately placed on ice after defrosting at room temperature;
(2) it is outstanding in E.coli DH5 α competent cells that the recombinant plasmid PET-28a+fimH solution that step 5 obtains is added
It in liquid, gently shakes up, places 30min on ice;
(3) 42 DEG C of water-bath heat shock 90s, are immediately placed on cooled on ice 5min;
(4) after the LB liquid medium mixing of 1mL being added, 37 DEG C of shaken cultivation 40min make thalline restore normal growth shape
State;
(5) it takes 100 μ L to be coated on LB resistance plates after shaking up above-mentioned bacterium solution, is inverted culture dish, 37 DEG C of constant incubator trainings
Support 12h;
The formula of wherein LB resistances plate is as follows:Sodium chloride 10g/L, tryptone 10g/L, yeast powder 5g/L, agar powder
20g/L, 121 DEG C of sterilizing 20min, adds kanamycins to final concentration of 50 μ g/mL after cooling.
(6) from picking single bacterium colony on resistance plate, after protecting bacterium, plasmid PET-28a+fimH is extracted by step 3, after extraction
Plasmid PET-28a+fimH into row agarose gel electrophoresis verify and sequence verification as a result correctly see Fig. 3, plasmid PET-28a
The collection of illustrative plates of+fimH is shown in that Fig. 4, nucleotide sequence are shown in SEQ ID NO:3.
Seven, recombinant plasmid PET-28a+fimH is transformed into original Escherichia coli
Correct recombinant plasmid PET-28a+fimH will be verified according to step 6 and is transformed into the sense of original strain CIBTS1688
In by state cell, picking single bacterium colony carries out sequence verification, the recombination bacillus coli built by step 3 extraction plasmid
CIBTS1688fimH*。
Wherein, the competent cell of CIBTS1688 is prepared as follows:
(1) the fresh overnight CIBTS1688 cells bacterium solution that 500 μ L step 1 glycerine activate is gone into 50mL LB
In fluid nutrient medium, 3h (shaking table 200r/min) is shaken up in 37 DEG C of oscillations, measures OD600=0.8-1.0 or so;
(2) aseptically, 1.5mL inoculums are transferred in the centrifuge tube of ice precooling, are placed on ice
10min;
(3) and then in 4 DEG C of 4000r/min 10min is centrifuged;
(4) liquid is discarded supernatant, centrifuge tube is inverted 1min, residual culture solution is made to flow to end;
(5) respectively add the 0.1M CaCl of 150 μ L ice precooling2Cell is resuspended in aqueous solution, merges two pipes, ice bath 10min;
(6) and then in 4 DEG C of 4000r/min 10min is centrifuged;
(7) liquid is discarded supernatant, centrifuge tube is inverted 1min, remaining trace culture solution is made to flow to end;
(8) the 0.1M CaCl of 800 μ L ice precooling are first added2Cell is resuspended in aqueous solution, adds the 30%v/ of 25 μ L precoolings
It is spare to be sub-packed in -80 DEG C of storages later for the glycerine of v.
Embodiment 2
(1) respectively take 100 μ L glycerol bacterium CIBTS1688 and CIBTS1688fimH* that the 5mL LB liquid mediums of sterilizing are added
In be incubated overnight, activate;
(2) and then by 1:100 dilutions, 37 DEG C are shaken 5h slowly, reach logarithmic phase OD6000.8-1.0;
(3) take 2mL bacterium solutions in OD600Lower measurement light absorption value dilutes bacterium solution so that bacterium solution after dilution with the distilled water of sterilizing
OD600It is 0.01;
(4) take 200 μ L bacterium solutions that 96 orifice plates are added, LB liquid medium compares, and 37 DEG C of cultures are for 24 hours;
(5) 96 orifice plate bacterium solutions are poured out, is buffered 3 times, is patted dry with pure water;
(6) it takes 1% crystal violet solution, 200 μ L that 96 orifice plates are added, dyes 10min, tap water is rinsed, dried;
(7) it after taking 33% glacial acetic acid, 200 μ L that the dissolving of 96 orifice plates is added, gently vibrates, OD600Biomembrane yield is measured, is made even
Mean value:In 96 orifice plate cultures, OD values are 1.9-2.1 to CIBTS1688 for 24 hours, and CIBTS1688fimH* is in 96 orifice plate cultures OD for 24 hours
Value is 2.6-2.7, and biomembrane electron microscope is shown in Fig. 5 and Fig. 6 respectively.
Embodiment 3
(1) CIBTS1688fimH* glycerol stocks are inoculated in 5mL LB liquid mediums after taking 10 μ L CIBTS1688 and transformation
In, 37 DEG C, 200rpm overnight incubations;
(2) by volume 1:10 are inoculated in the bacterium solution that step (1) obtains in the LB liquid medium of 50mL, 37 DEG C,
200rpm cultivates 2h, and bacterial concentration reaches OD600=1.0 or so;
(3) bacterium solution is inoculated in fermentation medium by 5% ratio by volume, 37 DEG C, 200~250rpm, fermentation, Portugal
Grape sugar reacts after exhausting to be terminated, and the content of L-threonine in zymotic fluid is measured using high performance liquid chromatograph, the results are shown in Table 5, figure
7。
Wherein, fermentative medium formula is as follows:One glucose monohydrate 33g/L, sodium chloride 0.8g/L, ammonium sulfate 22g/L, three
Hypophosphite monohydrate hydrogen dipotassium 2.65g/L, epsom salt 0.8g/L, anhydrous cupric sulfate 0.02g/L, green-vitriol 0.02g/L, salt
Allithiamine 0.002g/L, yeast powder 1.0g/L, calcium carbonate 30g/L, pH7.2.
Wherein, HPLC detection methods are as follows:
Chromatographic condition:Sepax AA dedicated columns, 4.6*150mm, Detection wavelength 254nm, column temperature:36 DEG C, 5 μ L of sample size.
Derivating agent configures:Triethylamine acetonitrile solution:Triethylamine 1.4mL is taken, acetonitrile 2mL mixings are added;
Phenyl isothiocyanate acetonitrile solution:25 μ L of phenyl isothiocyanate are taken to add acetonitrile 2mL mixings.
Mobile phase A:The sodium acetate for weighing 15.2g adds water 1850mL, with glacial acetic acid tune pH value to 6.5 after dissolving.
Mobile phase B:80% acetonitrile (v/v);
Flow velocity:0.8mL/min, data acquisition time 50min.
Table 4 is HPLC gradient elution program
Table 5 is the L-threonine yield of genetic engineering bacterium
Note:Microflora is measured after fermentation stability, CIBTS1688 fermentation 36h threonines yield reach stablize and
Reach peak, sugar consumption terminates, and CIBTS1688fimH* fermentation 32h production amount of threonine, which reaches, stablizes and reach peak, sugar consumption
Terminate.
Embodiment 4
Method the results are shown in Table 6 with embodiment 3 the difference is that concentration of glucose is 100g/L.
The L-threonine yield of table 6 is concentration of glucose when being 100g/L genetic engineering bacterium
Sequence table
<110>Nanjing University of Technology
<120>A kind of Recombinant organism and its construction method and application
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 903
<212> DNA
<213> FimH
<400> 1
atgaaacgag ttattaccct gtttgctgta ctgctgatgg gctggtcggt aaatgcctgg 60
tcattcgcct gtaaaaccgc caatggtacc gctatcccta ttggcggtgg cagcgccaat 120
gtttatgtaa accttgcgcc cgtcgtgaat gtggggcaaa acctggtcgt ggatctttcg 180
acgcaaatct tttgccataa cgattatccg gaaaccatta cagactatgt cacactgcaa 240
cgaggctcgg cttatggcgg cgtgttatct aatttttccg ggaccgtaaa atatagtggc 300
agtagctatc catttcctac caccagcgaa acgccgcgcg ttgtttataa ttcgagaacg 360
gataagccgt ggccggtggc gctttatttg acgcctgtga gcagtgcggg cggggtggcg 420
attaaagctg gctcattaat tgccgtgctt attttgcgac agaccaacaa ctataacagc 480
gatgatttcc agtttgtgtg gaatatttac gccaataatg atgtggtggt gcctactggc 540
ggctgcgatg tttctgctcg tgatgtcacc gttactctgc cggactaccc tggttcagtg 600
ccaattcctc ttaccgttta ttgtgcgaaa agccaaaacc tggggtatta cctctccggc 660
acaaccgcag atgcgggcaa ctcgattttc accaataccg cgtcgttttc acctgcacag 720
ggcgtcggcg tacagttgac gcgcaacggt acgattattc cagcgaataa cacggtatcg 780
ttaggagcag tagggacttc ggcggtgagt ctgggattaa cggcaaatta tgcacgtacc 840
ggagggcagg tgactgcagg gaatgtgcaa tcgattattg gcgtgacttt tgtttatcaa 900
taa 903
<210> 2
<211> 5369
<212> DNA
<213> PET-28a
<400> 2
atccggatat agttcctcct ttcagcaaaa aacccctcaa gacccgttta gaggccccaa 60
ggggttatgc tagttattgc tcagcggtgg cagcagccaa ctcagcttcc tttcgggctt 120
tgttagcagc cggatctcag tggtggtggt ggtggtgctc gagtgcggcc gcaagcttgt 180
cgacggagct cgaattcgga tccgcgaccc atttgctgtc caccagtcat gctagccata 240
tggctgccgc gcggcaccag gccgctgctg tgatgatgat gatgatggct gctgcccatg 300
gtatatctcc ttcttaaagt taaacaaaat tatttctaga ggggaattgt tatccgctca 360
caattcccct atagtgagtc gtattaattt cgcgggatcg agatctcgat cctctacgcc 420
ggacgcatcg tggccggcat caccggcgcc acaggtgcgg ttgctggcgc ctatatcgcc 480
gacatcaccg atggggaaga tcgggctcgc cacttcgggc tcatgagcgc ttgtttcggc 540
gtgggtatgg tggcaggccc cgtggccggg ggactgttgg gcgccatctc cttgcatgca 600
ccattccttg cggcggcggt gctcaacggc ctcaacctac tactgggctg cttcctaatg 660
caggagtcgc ataagggaga gcgtcgagat cccggacacc atcgaatggc gcaaaacctt 720
tcgcggtatg gcatgatagc gcccggaaga gagtcaattc agggtggtga atgtgaaacc 780
agtaacgtta tacgatgtcg cagagtatgc cggtgtctct tatcagaccg tttcccgcgt 840
ggtgaaccag gccagccacg tttctgcgaa aacgcgggaa aaagtggaag cggcgatggc 900
ggagctgaat tacattccca accgcgtggc acaacaactg gcgggcaaac agtcgttgct 960
gattggcgtt gccacctcca gtctggccct gcacgcgccg tcgcaaattg tcgcggcgat 1020
taaatctcgc gccgatcaac tgggtgccag cgtggtggtg tcgatggtag aacgaagcgg 1080
cgtcgaagcc tgtaaagcgg cggtgcacaa tcttctcgcg caacgcgtca gtgggctgat 1140
cattaactat ccgctggatg accaggatgc cattgctgtg gaagctgcct gcactaatgt 1200
tccggcgtta tttcttgatg tctctgacca gacacccatc aacagtatta ttttctccca 1260
tgaagacggt acgcgactgg gcgtggagca tctggtcgca ttgggtcacc agcaaatcgc 1320
gctgttagcg ggcccattaa gttctgtctc ggcgcgtctg cgtctggctg gctggcataa 1380
atatctcact cgcaatcaaa ttcagccgat agcggaacgg gaaggcgact ggagtgccat 1440
gtccggtttt caacaaacca tgcaaatgct gaatgagggc atcgttccca ctgcgatgct 1500
ggttgccaac gatcagatgg cgctgggcgc aatgcgcgcc attaccgagt ccgggctgcg 1560
cgttggtgcg gatatctcgg tagtgggata cgacgatacc gaagacagct catgttatat 1620
cccgccgtta accaccatca aacaggattt tcgcctgctg gggcaaacca gcgtggaccg 1680
cttgctgcaa ctctctcagg gccaggcggt gaagggcaat cagctgttgc ccgtctcact 1740
ggtgaaaaga aaaaccaccc tggcgcccaa tacgcaaacc gcctctcccc gcgcgttggc 1800
cgattcatta atgcagctgg cacgacaggt ttcccgactg gaaagcgggc agtgagcgca 1860
acgcaattaa tgtaagttag ctcactcatt aggcaccggg atctcgaccg atgcccttga 1920
gagccttcaa cccagtcagc tccttccggt gggcgcgggg catgactatc gtcgccgcac 1980
ttatgactgt cttctttatc atgcaactcg taggacaggt gccggcagcg ctctgggtca 2040
ttttcggcga ggaccgcttt cgctggagcg cgacgatgat cggcctgtcg cttgcggtat 2100
tcggaatctt gcacgccctc gctcaagcct tcgtcactgg tcccgccacc aaacgtttcg 2160
gcgagaagca ggccattatc gccggcatgg cggccccacg ggtgcgcatg atcgtgctcc 2220
tgtcgttgag gacccggcta ggctggcggg gttgccttac tggttagcag aatgaatcac 2280
cgatacgcga gcgaacgtga agcgactgct gctgcaaaac gtctgcgacc tgagcaacaa 2340
catgaatggt cttcggtttc cgtgtttcgt aaagtctgga aacgcggaag tcagcgccct 2400
gcaccattat gttccggatc tgcatcgcag gatgctgctg gctaccctgt ggaacaccta 2460
catctgtatt aacgaagcgc tggcattgac cctgagtgat ttttctctgg tcccgccgca 2520
tccataccgc cagttgttta ccctcacaac gttccagtaa ccgggcatgt tcatcatcag 2580
taacccgtat cgtgagcatc ctctctcgtt tcatcggtat cattaccccc atgaacagaa 2640
atccccctta cacggaggca tcagtgacca aacaggaaaa aaccgccctt aacatggccc 2700
gctttatcag aagccagaca ttaacgcttc tggagaaact caacgagctg gacgcggatg 2760
aacaggcaga catctgtgaa tcgcttcacg accacgctga tgagctttac cgcagctgcc 2820
tcgcgcgttt cggtgatgac ggtgaaaacc tctgacacat gcagctcccg gagacggtca 2880
cagcttgtct gtaagcggat gccgggagca gacaagcccg tcagggcgcg tcagcgggtg 2940
ttggcgggtg tcggggcgca gccatgaccc agtcacgtag cgatagcgga gtgtatactg 3000
gcttaactat gcggcatcag agcagattgt actgagagtg caccatatat gcggtgtgaa 3060
ataccgcaca gatgcgtaag gagaaaatac cgcatcaggc gctcttccgc ttcctcgctc 3120
actgactcgc tgcgctcggt cgttcggctg cggcgagcgg tatcagctca ctcaaaggcg 3180
gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtg agcaaaaggc 3240
cagcaaaagg ccaggaaccg taaaaaggcc gcgttgctgg cgtttttcca taggctccgc 3300
ccccctgacg agcatcacaa aaatcgacgc tcaagtcaga ggtggcgaaa cccgacagga 3360
ctataaagat accaggcgtt tccccctgga agctccctcg tgcgctctcc tgttccgacc 3420
ctgccgctta ccggatacct gtccgccttt ctcccttcgg gaagcgtggc gctttctcat 3480
agctcacgct gtaggtatct cagttcggtg taggtcgttc gctccaagct gggctgtgtg 3540
cacgaacccc ccgttcagcc cgaccgctgc gccttatccg gtaactatcg tcttgagtcc 3600
aacccggtaa gacacgactt atcgccactg gcagcagcca ctggtaacag gattagcaga 3660
gcgaggtatg taggcggtgc tacagagttc ttgaagtggt ggcctaacta cggctacact 3720
agaaggacag tatttggtat ctgcgctctg ctgaagccag ttaccttcgg aaaaagagtt 3780
ggtagctctt gatccggcaa acaaaccacc gctggtagcg gtggtttttt tgtttgcaag 3840
cagcagatta cgcgcagaaa aaaaggatct caagaagatc ctttgatctt ttctacgggg 3900
tctgacgctc agtggaacga aaactcacgt taagggattt tggtcatgaa caataaaact 3960
gtctgcttac ataaacagta atacaagggg tgttatgagc catattcaac gggaaacgtc 4020
ttgctctagg ccgcgattaa attccaacat ggatgctgat ttatatgggt ataaatgggc 4080
tcgcgataat gtcgggcaat caggtgcgac aatctatcga ttgtatggga agcccgatgc 4140
gccagagttg tttctgaaac atggcaaagg tagcgttgcc aatgatgtta cagatgagat 4200
ggtcagacta aactggctga cggaatttat gcctcttccg accatcaagc attttatccg 4260
tactcctgat gatgcatggt tactcaccac tgcgatcccc gggaaaacag cattccaggt 4320
attagaagaa tatcctgatt caggtgaaaa tattgttgat gcgctggcag tgttcctgcg 4380
ccggttgcat tcgattcctg tttgtaattg tccttttaac agcgatcgcg tatttcgtct 4440
cgctcaggcg caatcacgaa tgaataacgg tttggttgat gcgagtgatt ttgatgacga 4500
gcgtaatggc tggcctgttg aacaagtctg gaaagaaatg cataaacttt tgccattctc 4560
accggattca gtcgtcactc atggtgattt ctcacttgat aaccttattt ttgacgaggg 4620
gaaattaata ggttgtattg atgttggacg agtcggaatc gcagaccgat accaggatct 4680
tgccatccta tggaactgcc tcggtgagtt ttctccttca ttacagaaac ggctttttca 4740
aaaatatggt attgataatc ctgatatgaa taaattgcag tttcatttga tgctcgatga 4800
gtttttctaa gaattaattc atgagcggat acatatttga atgtatttag aaaaataaac 4860
aaataggggt tccgcgcaca tttccccgaa aagtgccacc tgaaattgta aacgttaata 4920
ttttgttaaa attcgcgtta aatttttgtt aaatcagctc attttttaac caataggccg 4980
aaatcggcaa aatcccttat aaatcaaaag aatagaccga gatagggttg agtgttgttc 5040
cagtttggaa caagagtcca ctattaaaga acgtggactc caacgtcaaa gggcgaaaaa 5100
ccgtctatca gggcgatggc ccactacgtg aaccatcacc ctaatcaagt tttttggggt 5160
cgaggtgccg taaagcacta aatcggaacc ctaaagggag cccccgattt agagcttgac 5220
ggggaaagcc ggcgaacgtg gcgagaaagg aagggaagaa agcgaaagga gcgggcgcta 5280
gggcgctggc aagtgtagcg gtcacgctgc gcgtaaccac cacacccgcc gcgcttaatg 5340
cgccgctaca gggcgcgtcc cattcgcca 5369
<210> 3
<211> 6227
<212> DNA
<213> PET-28a+fimH
<400> 3
atccggatat agttcctcct ttcagcaaaa aacccctcaa gacccgttta gaggccccaa 60
ggggttatgc tagttattgc tcagcggtgg cagcagccaa ctcagcttcc tttcgggctt 120
tgttagcagc cggatctcag tggtggtggt ggtggtgctc gagtgcggcc gcaagcttgt 180
cgacggagct cgaattcgga tccgcgaccc atttgctgtc caccagtcat gctagccata 240
tggctgccgc gcggcaccag gccgctgctg tgatgatgat gatgatggct gctgcttatt 300
gataaacaaa agtcacgcca ataatcgatt gcacattccc tgcagtcacc tgccctccgg 360
tacgtgcata atttgccgtt aatcccagac tcaccgccga agtccctact gctcctaacg 420
ataccgtgtt attcgctgga ataatcgtac cgttgcgcgt caactgtacg ccgacgccct 480
gtgcaggtga aaacgacgcg gtattggtga aaatcgagtt gcccgcatct gcggttgtgc 540
cggagaggta ataccccagg ttttggcttt tcgcacaata aacggtaaga ggaattggca 600
ctgaaccagg gtagtccggc agagtaacgg tgacatcacg agcagaaaca tcgcagccgc 660
cagtaggcac caccacatca ttattggcgt aaatattcca cacaaactgg aaatcatcgc 720
tgttatagtt gttggtctgt cgcaaaataa gcacggcaat taatgagcca gctttaatcg 780
ccaccccgcc cgcactgctc acaggcgtca aataaagcgc caccggccac ggcttatccg 840
ttctcgaatt ataaacaacg cgcggcgttt cgctggtggt aggaaatgga tagctactgc 900
cactatattt tacggtcccg gaaaaattag ataacacgcc gccataagcc gagcctcgtt 960
gcagtgtgac atagtctgta atggtttccg gataatcgtt atggcaaaag atttgcgtcg 1020
aaagatccac gaccaggttt tgccccacat tcacgacggg cgcaaggttt acataaacat 1080
tggcgctgcc accgccaata gggatagcgg taccattggc ggttttacag gcgaatgacc 1140
aggcatttac cgaccagccc atcagcagta cagcaaacag ggtaataact cgtttcatgg 1200
ggaattgtta tccgctcaca attcccctat agtgagtcgt attaatttcg cgggatcgag 1260
atctcgatcc tctacgccgg acgcatcgtg gccggcatca ccggcgccac aggtgcggtt 1320
gctggcgcct atatcgccga catcaccgat ggggaagatc gggctcgcca cttcgggctc 1380
atgagcgctt gtttcggcgt gggtatggtg gcaggccccg tggccggggg actgttgggc 1440
gccatctcct tgcatgcacc attccttgcg gcggcggtgc tcaacggcct caacctacta 1500
ctgggctgct tcctaatgca ggagtcgcat aagggagagc gtcgagatcc cggacaccat 1560
cgaatggcgc aaaacctttc gcggtatggc atgatagcgc ccggaagaga gtcaattcag 1620
ggtggtgaat gtgaaaccag taacgttata cgatgtcgca gagtatgccg gtgtctctta 1680
tcagaccgtt tcccgcgtgg tgaaccaggc cagccacgtt tctgcgaaaa cgcgggaaaa 1740
agtggaagcg gcgatggcgg agctgaatta cattcccaac cgcgtggcac aacaactggc 1800
gggcaaacag tcgttgctga ttggcgttgc cacctccagt ctggccctgc acgcgccgtc 1860
gcaaattgtc gcggcgatta aatctcgcgc cgatcaactg ggtgccagcg tggtggtgtc 1920
gatggtagaa cgaagcggcg tcgaagcctg taaagcggcg gtgcacaatc ttctcgcgca 1980
acgcgtcagt gggctgatca ttaactatcc gctggatgac caggatgcca ttgctgtgga 2040
agctgcctgc actaatgttc cggcgttatt tcttgatgtc tctgaccaga cacccatcaa 2100
cagtattatt ttctcccatg aagacggtac gcgactgggc gtggagcatc tggtcgcatt 2160
gggtcaccag caaatcgcgc tgttagcggg cccattaagt tctgtctcgg cgcgtctgcg 2220
tctggctggc tggcataaat atctcactcg caatcaaatt cagccgatag cggaacggga 2280
aggcgactgg agtgccatgt ccggttttca acaaaccatg caaatgctga atgagggcat 2340
cgttcccact gcgatgctgg ttgccaacga tcagatggcg ctgggcgcaa tgcgcgccat 2400
taccgagtcc gggctgcgcg ttggtgcgga tatctcggta gtgggatacg acgataccga 2460
agacagctca tgttatatcc cgccgttaac caccatcaaa caggattttc gcctgctggg 2520
gcaaaccagc gtggaccgct tgctgcaact ctctcagggc caggcggtga agggcaatca 2580
gctgttgccc gtctcactgg tgaaaagaaa aaccaccctg gcgcccaata cgcaaaccgc 2640
ctctccccgc gcgttggccg attcattaat gcagctggca cgacaggttt cccgactgga 2700
aagcgggcag tgagcgcaac gcaattaatg taagttagct cactcattag gcaccgggat 2760
ctcgaccgat gcccttgaga gccttcaacc cagtcagctc cttccggtgg gcgcggggca 2820
tgactatcgt cgccgcactt atgactgtct tctttatcat gcaactcgta ggacaggtgc 2880
cggcagcgct ctgggtcatt ttcggcgagg accgctttcg ctggagcgcg acgatgatcg 2940
gcctgtcgct tgcggtattc ggaatcttgc acgccctcgc tcaagccttc gtcactggtc 3000
ccgccaccaa acgtttcggc gagaagcagg ccattatcgc cggcatggcg gccccacggg 3060
tgcgcatgat cgtgctcctg tcgttgagga cccggctagg ctggcggggt tgccttactg 3120
gttagcagaa tgaatcaccg atacgcgagc gaacgtgaag cgactgctgc tgcaaaacgt 3180
ctgcgacctg agcaacaaca tgaatggtct tcggtttccg tgtttcgtaa agtctggaaa 3240
cgcggaagtc agcgccctgc accattatgt tccggatctg catcgcagga tgctgctggc 3300
taccctgtgg aacacctaca tctgtattaa cgaagcgctg gcattgaccc tgagtgattt 3360
ttctctggtc ccgccgcatc cataccgcca gttgtttacc ctcacaacgt tccagtaacc 3420
gggcatgttc atcatcagta acccgtatcg tgagcatcct ctctcgtttc atcggtatca 3480
ttacccccat gaacagaaat cccccttaca cggaggcatc agtgaccaaa caggaaaaaa 3540
ccgcccttaa catggcccgc tttatcagaa gccagacatt aacgcttctg gagaaactca 3600
acgagctgga cgcggatgaa caggcagaca tctgtgaatc gcttcacgac cacgctgatg 3660
agctttaccg cagctgcctc gcgcgtttcg gtgatgacgg tgaaaacctc tgacacatgc 3720
agctcccgga gacggtcaca gcttgtctgt aagcggatgc cgggagcaga caagcccgtc 3780
agggcgcgtc agcgggtgtt ggcgggtgtc ggggcgcagc catgacccag tcacgtagcg 3840
atagcggagt gtatactggc ttaactatgc ggcatcagag cagattgtac tgagagtgca 3900
ccatatatgc ggtgtgaaat accgcacaga tgcgtaagga gaaaataccg catcaggcgc 3960
tcttccgctt cctcgctcac tgactcgctg cgctcggtcg ttcggctgcg gcgagcggta 4020
tcagctcact caaaggcggt aatacggtta tccacagaat caggggataa cgcaggaaag 4080
aacatgtgag caaaaggcca gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg 4140
tttttccata ggctccgccc ccctgacgag catcacaaaa atcgacgctc aagtcagagg 4200
tggcgaaacc cgacaggact ataaagatac caggcgtttc cccctggaag ctccctcgtg 4260
cgctctcctg ttccgaccct gccgcttacc ggatacctgt ccgcctttct cccttcggga 4320
agcgtggcgc tttctcatag ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc 4380
tccaagctgg gctgtgtgca cgaacccccc gttcagcccg accgctgcgc cttatccggt 4440
aactatcgtc ttgagtccaa cccggtaaga cacgacttat cgccactggc agcagccact 4500
ggtaacagga ttagcagagc gaggtatgta ggcggtgcta cagagttctt gaagtggtgg 4560
cctaactacg gctacactag aaggacagta tttggtatct gcgctctgct gaagccagtt 4620
accttcggaa aaagagttgg tagctcttga tccggcaaac aaaccaccgc tggtagcggt 4680
ggtttttttg tttgcaagca gcagattacg cgcagaaaaa aaggatctca agaagatcct 4740
ttgatctttt ctacggggtc tgacgctcag tggaacgaaa actcacgtta agggattttg 4800
gtcatgaaca ataaaactgt ctgcttacat aaacagtaat acaaggggtg ttatgagcca 4860
tattcaacgg gaaacgtctt gctctaggcc gcgattaaat tccaacatgg atgctgattt 4920
atatgggtat aaatgggctc gcgataatgt cgggcaatca ggtgcgacaa tctatcgatt 4980
gtatgggaag cccgatgcgc cagagttgtt tctgaaacat ggcaaaggta gcgttgccaa 5040
tgatgttaca gatgagatgg tcagactaaa ctggctgacg gaatttatgc ctcttccgac 5100
catcaagcat tttatccgta ctcctgatga tgcatggtta ctcaccactg cgatccccgg 5160
gaaaacagca ttccaggtat tagaagaata tcctgattca ggtgaaaata ttgttgatgc 5220
gctggcagtg ttcctgcgcc ggttgcattc gattcctgtt tgtaattgtc cttttaacag 5280
cgatcgcgta tttcgtctcg ctcaggcgca atcacgaatg aataacggtt tggttgatgc 5340
gagtgatttt gatgacgagc gtaatggctg gcctgttgaa caagtctgga aagaaatgca 5400
taaacttttg ccattctcac cggattcagt cgtcactcat ggtgatttct cacttgataa 5460
ccttattttt gacgagggga aattaatagg ttgtattgat gttggacgag tcggaatcgc 5520
agaccgatac caggatcttg ccatcctatg gaactgcctc ggtgagtttt ctccttcatt 5580
acagaaacgg ctttttcaaa aatatggtat tgataatcct gatatgaata aattgcagtt 5640
tcatttgatg ctcgatgagt ttttctaaga attaattcat gagcggatac atatttgaat 5700
gtatttagaa aaataaacaa ataggggttc cgcgcacatt tccccgaaaa gtgccacctg 5760
aaattgtaaa cgttaatatt ttgttaaaat tcgcgttaaa tttttgttaa atcagctcat 5820
tttttaacca ataggccgaa atcggcaaaa tcccttataa atcaaaagaa tagaccgaga 5880
tagggttgag tgttgttcca gtttggaaca agagtccact attaaagaac gtggactcca 5940
acgtcaaagg gcgaaaaacc gtctatcagg gcgatggccc actacgtgaa ccatcaccct 6000
aatcaagttt tttggggtcg aggtgccgta aagcactaaa tcggaaccct aaagggagcc 6060
cccgatttag agcttgacgg ggaaagccgg cgaacgtggc gagaaaggaa gggaagaaag 6120
cgaaaggagc gggcgctagg gcgctggcaa gtgtagcggt cacgctgcgc gtaaccacca 6180
cacccgccgc gcttaatgcg ccgctacagg gcgcgtccca ttcgcca 6227
Claims (8)
1. a kind of Recombinant organism, which is characterized in that original Escherichia coli have imported the recombination for carrying fimH genes
Plasmid.
2. a kind of Recombinant organism according to claim 1, which is characterized in that the original Escherichia coli are
CCTCC NO:M 2015233。
3. a kind of Recombinant organism according to claim 1, which is characterized in that the recombinant plasmid is to carry
The PET-28a plasmids of fimH genes.
4. the construction method of Recombinant organism described in claim 1-3 any one, which is characterized in that including following
Step:
(1) genome of original Escherichia coli is extracted;
(2) genome obtained using step (1) extraction expands fimH genes as template using round pcr;
(3) the fimH genes for obtaining step (2) are inserted between I/Xba of Nco, I restriction enzyme sites of PET-28a plasmids, are carried
The recombinant plasmid of fimH genes;
(4) in the recombinant plasmid transformed for obtaining step (3) to the competent cell of E.coli DH5 α, from E.coli DH5 α
Extract recombinant plasmid;
(5) to get large intestine bar in the recombinant plasmid transformed to the competent cell of original Escherichia coli for obtaining step (4) extraction
Bacterium genetic engineering bacterium.
5. construction method according to claim 4, which is characterized in that original Escherichia coli described in step (1) are CCTCC
NO:M 2015233。
6. construction method according to claim 4, which is characterized in that the primer that PCR is used described in step (2) is as follows:
fimH-F:GGATAACAATTCCCCTCTAGAATGAAACGAGTTATTACCCTGTTTGC
fimH-R:GATGATGGCTGCTGCCCATGGTTATTGATAAACAAAAGTCACGCCA.
7. application of the Recombinant organism in production of L-threonine by fermentation described in claim 1-3 any one.
8. application according to claim 7, which is characterized in that fermentation condition is as follows:Fermentation temperature is 25~37 DEG C, fermentation
Time is 30~32h.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810336575.9A CN108531439B (en) | 2018-04-16 | 2018-04-16 | Escherichia coli genetic engineering bacterium and construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810336575.9A CN108531439B (en) | 2018-04-16 | 2018-04-16 | Escherichia coli genetic engineering bacterium and construction method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108531439A true CN108531439A (en) | 2018-09-14 |
CN108531439B CN108531439B (en) | 2020-04-07 |
Family
ID=63481192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810336575.9A Active CN108531439B (en) | 2018-04-16 | 2018-04-16 | Escherichia coli genetic engineering bacterium and construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108531439B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109266578A (en) * | 2018-09-25 | 2019-01-25 | 江苏澳创生物科技有限公司 | Escherichia coli ACThr1032 and its application in production of L-threonine by fermentation |
CN109576198A (en) * | 2018-11-09 | 2019-04-05 | 南京工业大学 | One plant of recombination bacillus coli for knocking out fimA gene and its construction method and application |
CN110055205A (en) * | 2019-05-13 | 2019-07-26 | 南京工业大学 | A kind of recombination bacillus coli knocking out fimH gene and its construction method and application |
CN110079567A (en) * | 2019-05-13 | 2019-08-02 | 南京工业大学 | A kind of application of the recombination bacillus coli in fermenting and producing amino acid being overexpressed fimH gene |
CN114015678A (en) * | 2021-09-30 | 2022-02-08 | 中南民族大学 | Aminopeptidase Amp0279 derived from Bacillus sphaericus C3-41 as well as recombinant strain and application thereof |
CN114317389A (en) * | 2021-12-22 | 2022-04-12 | 南京工业大学 | Method for producing L-threonine by co-culture fermentation of recombinant escherichia coli |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006078039A1 (en) * | 2005-01-18 | 2006-07-27 | Ajinomoto Co., Inc. | L-amino acid producing microorganism and a method for producing l-amino acid |
CN101307301A (en) * | 2007-05-17 | 2008-11-19 | 浙江升华拜克生物股份有限公司 | L-tryptophan genetic engineering bacterium and process for producing L-tryptophan |
CN104862329A (en) * | 2015-04-23 | 2015-08-26 | 上海工业生物技术研发中心 | L-threonine genetic engineering production bacteria |
CN104870464A (en) * | 2012-07-24 | 2015-08-26 | 国家科研中心 | Multimeric mannosides, a process for preparing the same and their uses as a drug |
CN105176906A (en) * | 2015-10-20 | 2015-12-23 | 上海工业生物技术研发中心 | L-threonine gene engineering producing strain |
CN106062203A (en) * | 2013-10-11 | 2016-10-26 | 格林考瓦因有限公司 | Methods of host cell modification |
CN106535927A (en) * | 2014-02-24 | 2017-03-22 | 格林考瓦因有限公司 | Novel polysaccharide and uses thereof |
-
2018
- 2018-04-16 CN CN201810336575.9A patent/CN108531439B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006078039A1 (en) * | 2005-01-18 | 2006-07-27 | Ajinomoto Co., Inc. | L-amino acid producing microorganism and a method for producing l-amino acid |
CN101307301A (en) * | 2007-05-17 | 2008-11-19 | 浙江升华拜克生物股份有限公司 | L-tryptophan genetic engineering bacterium and process for producing L-tryptophan |
CN104870464A (en) * | 2012-07-24 | 2015-08-26 | 国家科研中心 | Multimeric mannosides, a process for preparing the same and their uses as a drug |
CN106062203A (en) * | 2013-10-11 | 2016-10-26 | 格林考瓦因有限公司 | Methods of host cell modification |
CN106535927A (en) * | 2014-02-24 | 2017-03-22 | 格林考瓦因有限公司 | Novel polysaccharide and uses thereof |
CN104862329A (en) * | 2015-04-23 | 2015-08-26 | 上海工业生物技术研发中心 | L-threonine genetic engineering production bacteria |
CN105176906A (en) * | 2015-10-20 | 2015-12-23 | 上海工业生物技术研发中心 | L-threonine gene engineering producing strain |
Non-Patent Citations (1)
Title |
---|
尹晓琳等: "尿路致病性大肠杆菌Ⅰ型菌毛fimH和fimC基因原核表达质粒的构建及表达", 《中国人兽共患病学报》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109266578A (en) * | 2018-09-25 | 2019-01-25 | 江苏澳创生物科技有限公司 | Escherichia coli ACThr1032 and its application in production of L-threonine by fermentation |
CN109266578B (en) * | 2018-09-25 | 2020-06-23 | 江苏澳创生物科技有限公司 | Escherichia coli ACThr1032 and application thereof in fermentation production of L-threonine |
CN109576198A (en) * | 2018-11-09 | 2019-04-05 | 南京工业大学 | One plant of recombination bacillus coli for knocking out fimA gene and its construction method and application |
CN109576198B (en) * | 2018-11-09 | 2022-06-07 | 南京工业大学 | Recombinant escherichia coli with fimA gene knocked out, and construction method and application thereof |
CN110055205A (en) * | 2019-05-13 | 2019-07-26 | 南京工业大学 | A kind of recombination bacillus coli knocking out fimH gene and its construction method and application |
CN110079567A (en) * | 2019-05-13 | 2019-08-02 | 南京工业大学 | A kind of application of the recombination bacillus coli in fermenting and producing amino acid being overexpressed fimH gene |
CN114015678A (en) * | 2021-09-30 | 2022-02-08 | 中南民族大学 | Aminopeptidase Amp0279 derived from Bacillus sphaericus C3-41 as well as recombinant strain and application thereof |
CN114317389A (en) * | 2021-12-22 | 2022-04-12 | 南京工业大学 | Method for producing L-threonine by co-culture fermentation of recombinant escherichia coli |
Also Published As
Publication number | Publication date |
---|---|
CN108531439B (en) | 2020-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108531439B (en) | Escherichia coli genetic engineering bacterium and construction method and application thereof | |
CN112725256B (en) | Recombinant escherichia coli and method for biosynthesizing diosmetin by using recombinant escherichia coli | |
CN109679989A (en) | A method of improving base editing system editorial efficiency | |
AU2021232763A1 (en) | Methods for Nucleic Acid Assembly and High Throughput Sequencing | |
US11702640B2 (en) | Monooxygenase mutant, preparation method and application thereof | |
CN109825488A (en) | A kind of new method carrying out xylanase secretion expression in Escherichia coli | |
KR20150014953A (en) | Ketol-acid reductoisomerase enzymes and methods of use | |
KR20130116858A (en) | Extraction solvents derived from oil for alcohol removal in extractive fermentation | |
CN111065738A (en) | Gene therapy DNA vector VTvaf17, method of production; escherichia coli strain SCS110-AF, a generation method; escherichia coli strain SCS110-AF/VTvaf17 carrying gene therapy DNA vector VTvaf17, and its production method | |
CN110577965B (en) | Application of xCas9n-epBE base editing system in gene editing | |
CN114410560B (en) | Engineering strain for high-yield FK228 and construction and application thereof | |
CN108165617A (en) | Chloroplast genomic dna separation, sequencing new method, kit and its application | |
Carnes et al. | Plasmid DNA production combining antibiotic‐free selection, inducible high yield fermentation, and novel autolytic purification | |
CN114369560A (en) | Method for improving biological indigo yield | |
CN111607545B (en) | Recombinant bacterium for high-yield farnesene as well as construction method and application thereof | |
CN112375781B (en) | Application of pC1300-MAS-Cas9 gene editing system in 84K poplar gene editing | |
CN112280799B (en) | Method for site-directed mutagenesis of hevea brasiliensis or dandelion gene by using CRISPR/Cas9 system | |
CN110982818B (en) | Application of nuclear localization signal F4NLS in efficient creation of rice herbicide resistant material | |
CN109666693B (en) | Application of MG132 in editing receptor genome by base editing system | |
CN110951773B (en) | Application of FNLS-sABE system in creating rice herbicide resistant material | |
Pakula et al. | Characterization of a DNA binding protein of bacteriophage PRD1 involved in DNA replication | |
CN109266673A (en) | A kind of coli expression carrier pBMcopA and its application | |
CN115074304B (en) | Corynebacterium glutamicum mutant and recombinant bacterium construction method and application | |
CN113462697B (en) | Degradable glyphosate-resistant gene, plant expression vector, cultivation method of degradable glyphosate-resistant transgenic rice and application | |
CN113789362B (en) | Method for synthesizing 16 alpha-hydroxylated steroid compound by using cytochrome P450 enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |